This paper reports the first in-human trial exploring surgical reduction therapy for hypertrophic obstructive cardiomyopathy (HOCM). Patients recruited to the trial were those who presented with refractory HOCM with disabling symptoms despite best medical management.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Electrophysiology/arrhythmia
August 17, 2023
April 5, 2022
A brief but comprehensive editorial on nuances of the links between atrial fibrillation and heart failure, apropos a trial we have commented recently on, by the Johns Hopkins team that develops the calmodulin-dependent protein kinase II inhibitor molecules
March 4, 2022
A paper that addresses a gap in knowledge and will guide future research: of particular interest, the penultimate paragraph on The Role of Interventions.
February 28, 2022
An interesting brief editorial on an experiment revisiting renal denervation as a panacea to cardiovascular disease
November 23, 2021
The video demonstrates the technique for performing the FDA approved Convergent Procedure to treat persistent and long-standing persistent atrial fibrillation
November 18, 2021
The video provides insights into career opportunities and choices, and the evolution to advanced surgical treatment of atrial fibrillation.
June 15, 2021
This video illustrates the epicardial part of the convergent procedure with application of a left atrial appendage clip all through a left thoracoscopic approach.
May 27, 2021
This month's update on the economical and general aspects of the ROOBY-FS trial. The conclusion (on no impact of de novo post-CABG AF on the incidence of stroke nor the 5 year expenditure ) challenges many hitherto perceptions on this frequent compication of coronary surgery.
May 21, 2021
A large RCT concluding that 'surgical occlusion of the left atrial appendage provides additional protection against stroke when added to anticoagulation.' A number of limitations are briefly discussed. Findings are interesting in that absolute absence of surgical complications has been declared.
May 20, 2021
This video will present a novel way to perform totally endoscopic, epicardial beating heart surgical ablation along with advanced epi-endocardial mapping in a hybrid setting.